Scott Weinberg

Scott Weinberg has a diverse work experience spanning over several companies and roles. Scott is currently serving as the Executive Director, Controller at Nimbus Therapeutics since May 2022. Prior to this, they worked at Inozyme Pharma, where they held the positions of Senior Director, Financial Management from September 2020 to May 2022, and Controller from April 2019 to September 2020.

Before joining Inozyme Pharma, Weinberg worked at CarGurus as the Corporate Controller from May 2014 to February 2019. Scott also held the position of Global Controller at ModusLink Global Solutions, a publicly traded company, from May 2010 to March 2014. At ModusLink, they were responsible for managing the global accounting operations of the company and leading a team of approximately 65 employees.

Weinberg's career started at Deloitte, where they worked as an Auditor from 1990 to 1993. Scott then moved on to Boston Scientific, where they served in the role of Internal Control and Analysis from 1993 to 1997. After that, they joined Modus Media International as an Accounting Manager from July 1997 to July 2000.

Weinberg's experience also includes working at Open Channel Solutions as the Corporate Controller from July 2000 to May 2010. During their tenure there, the company was sold in 2009. Open Channel Solutions was a developer of licensing and entitlement management software, with offices in various countries.

Overall, Weinberg's career has provided him with extensive financial management experience in various industries and organizations of different sizes.

Scott Weinberg attended Boston University from 1986 to 1990, where they pursued a Bachelor of Science in Business Administration (BSBA) with a focus on Accounting. No additional certifications or information about specific institutions or years of attainment were provided.